News

bit.bio’s Founder and CEO Dr Mark Kotter on creating every cell type and kickstarting a cell therapy revolution.

bit.bio is supporting the iGEM team from University of Cambridge in the iGEM synbio competition.

In this Financial Times piece our CEO is reflecting on raising concerns about the lab spaces for rent within science clusters. 

This piece covers how bit.bio's technology is also used by Meatable for their cultured meat products.

bit.bio CEO and founder welcomes Meatable's cultured meat sausage, powered by opti-ox.

Dr Farah Patell-Socha and Furqan Iqbal interviewed in the latest issue of Technology Networks.

VP of Research Products Dr Farah Patell-Socha discusses more accurate cell models in neurodegeneration.

CEO Mark Kotter gives an evening lecture at the famous Royal Institution on the cell reprogramming revolution.